CLINICAL TRIALS PROFILE FOR LUSEDRA
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
All Clinical Trials for Lusedra
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00209521 ↗ | Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery | Completed | PPD | Phase 2 | 2002-06-01 | This is an exploratory clinical trial designed to examine the efficacy, safety and tolerability of fospropofol (AQUAVAN) Injection compared to propofol (DISOPRIVAN) Injectable Emulsion when used to preoperatively sedate, induce, and maintain general anesthesia and to postoperatively sedate patients undergoing elective coronary artery surgery. |
| NCT00209521 ↗ | Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery | Completed | Eisai Inc. | Phase 2 | 2002-06-01 | This is an exploratory clinical trial designed to examine the efficacy, safety and tolerability of fospropofol (AQUAVAN) Injection compared to propofol (DISOPRIVAN) Injectable Emulsion when used to preoperatively sedate, induce, and maintain general anesthesia and to postoperatively sedate patients undergoing elective coronary artery surgery. |
| NCT01127438 ↗ | A Dose-ranging Study to Evaluate the Safety and Efficacy of LUSEDRA (Fospropofol Disodium) as an Intravenous Sedative for Diagnostic or Therapeutic Colonoscopy in Adult Special Populations | Completed | Eisai Inc. | Phase 4 | 2010-04-01 | The purpose of this study is to evaluate the safety and efficacy of LUSEDRA (fospropofol disodium) and to determine whether a dose lower than currently approved can provide effective moderate sedation required to complete diagnostic or therapeutic procedures. |
| NCT01195103 ↗ | Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery | Terminated | Eisai Inc. | Phase 4 | 2011-02-01 | How does Lusedra compare with current standard of care (midazolam) for minimal to moderate sedation for regional anesthesia blocks prior to orthopedic surgery? |
| NCT01195103 ↗ | Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery | Terminated | Mayo Clinic | Phase 4 | 2011-02-01 | How does Lusedra compare with current standard of care (midazolam) for minimal to moderate sedation for regional anesthesia blocks prior to orthopedic surgery? |
| NCT01260142 ↗ | A PK/PD Study of Fospropofol Disodium Compared With Propofol Injectable Emulsion | Completed | Eisai Inc. | Phase 4 | 2010-11-01 | This study is designed to characterize the pharmacokinetic and pharmacodynamic effect of fospropofol disodium in comparison to propofol. In addition, the study will compare the maximum sedative effect, safety and tolerability of fospropofol disodium and propofol. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Lusedra
Condition Name
Clinical Trial Locations for Lusedra
Trials by Country
Clinical Trial Progress for Lusedra
Clinical Trial Phase
Clinical Trial Sponsors for Lusedra
Sponsor Name
